Showing results (201-210 of 274) with videos related to
Sort By:
Pageof 28
Wiener Klinische Wochenschrift|May 30, 1975
[The Moschcowitz syndrome--a rare cause of coma of unknown aetiology (author's transl)]H Pall, K Jellinger, G Kleinberger, et al.Brain : a Journal of Neurology|December 1, 1994
Patterns of oligodendroglia pathology in multiple sclerosisK Ozawa, G Suchanek, H Breitschopf, et al.Acta Neuropathologica|August 15, 1998
Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob diseaseJ A Hainfellner, J Wanschitz, K Jellinger, et al.European Journal of Neurology|January 27, 2010
Decision-making for and impact of early immunomodulatory treatment: the Austrian Clinically Isolated Syndrome Study (ACISS)F Fazekas, U Baumhackl, T Berger, et al.Brain : a Journal of Neurology|October 24, 2008
Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaS Jarius, F Aboul-Enein, P Waters, et al.Wiener Medizinische Wochenschrift (1946)|June 5, 1998
[Epidemiology of transmissible spongiform encephalopathies (prion diseases) in Austria]C Radbauer, J A Hainfellner, K Jellinger, et al.Acta Neuropathologica|January 1, 1995
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situH Lassmann, C Bancher, H Breitschopf, et al.Journal of the Neurological Sciences|June 19, 2012
Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistryS Jarius, D Franciotta, F Paul, et al.The American Journal of Pathology|November 7, 1999
Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell deathC Stadelmann, T L Deckwerth, A Srinivasan, et al.Clinical Chemistry and Laboratory Medicine|December 16, 1998
Activated immune system in patients with Huntington's diseaseF Leblhuber, J Walli, K Jellinger, et al.Pageof 28